A major breakthrough in cancer investigation is arising with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently lost in many types of tumors, resulting https://thebookmarkage.com/story21929108/mini-antibodies-reactivate-the-p53-protein-the-promising-approach-for-malignant-therapy